CMOTEC B logo

Scandinavian ChemoTech AB (publ) Stock Price

OM:CMOTEC B Community·SEK 98.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CMOTEC B Share Price Performance

SEK 3.85
2.50 (185.19%)
SEK 3.85
2.50 (185.19%)
Price SEK 3.85

CMOTEC B Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with slight risk.

4 Risks
2 Rewards

Scandinavian ChemoTech AB (publ) Key Details

SEK 12.3m

Revenue

SEK 2.0m

Cost of Revenue

SEK 10.3m

Gross Profit

SEK 18.4m

Other Expenses

-SEK 8.1m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 28, 2026
-0.32
83.81%
-65.58%
0%
View Full Analysis

About CMOTEC B

Founded
2013
Employees
1
CEO
Stefan Frick
WebsiteView website
chemotech.se

Scandinavian ChemoTech AB (publ), a medical technology company, engages in the radiation physics, surgical oncology, and clinical development in Sweden and internationally. It operates in two divisions, Human Care and Animal Care. The company offers IQWave, an electroporation that generates a tumour-specific electrical stimulation; and veterinary medicines under the vetIQur name. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.

Recent CMOTEC B News & Updates

Recent updates

No updates